MIG Capital
VC Fund
München, Germany
MIG Capital is a VC fund in München focused on Biotechnology and Health Care. MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.
- Total investments:
- 97
- Last investment:
- Lead investor:
- 44%
- Fund size:
- $70M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries MIG Capital invests in
Stages MIG Capital invests in
Countries MIG Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $2.2M–$40M
- Series B
- $1.6M–$60M
Investment Focus
Industry
- Biotechnology 18 (19%)
- Health Care 10 (10%)
- Software 6 (6%)
- Therapeutics 6 (6%)
- Manufacturing 6 (6%)
Stage
- Series A 21 (22%)
- Series B 12 (12%)
- Funding Round 11 (11%)
- Seed 9 (9%)
- Series C 5 (5%)
Country
- Germany 27 (28%)
- France 5 (5%)
- Austria 3 (3%)
- Switzerland 2 (2%)
- Canada 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Axel Thierauf
Venture Partner
|
Venture Partner | Total investments: 5 | Find email | |
|
Boris Bernstein
Venture Partner
|
Venture Partner | Total investments: 3 | Find email | |
|
Dr. Klaus Feix
Venture Partner
|
Venture Partner | Total investments: 1 | Find email | |
Frederick Michna
Principal
|
Principal | Total investments: 1 | Find email | |
Jürgen Kosch
General Partner
|
General Partner | Total investments: 0 | Find email | |
| See all 11 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
GlassPoint Solar
|
GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California. | $20M / Venture - Series Unknown / Jan 26, 2026 | |
NcodiN
|
NcodiN develops nanophotonic chips for data transport for processors that improves speed, energy efficiency and heating of the circuit | $18.5M / Seed / Nov 20, 2025 | |
Zadient Technologies
|
Zadient Technologies is a company engaged in production of synthetic silicon carbide a building block for power semiconductors. | $40.4M / Series A / Nov 20, 2025 | |
AMSilk
|
AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics. | $35.1M / Sep 09, 2025 | |
ASTRA Therapeutics
|
ASTRA Therapeutics is a medication development business that uses cutting-edge science and technology to discover new therapeutic treatment candidates for the full spectrum of parasite disorders. | $9.7M / Seed / Jul 24, 2025 | |
Look Up Space
|
Look Up Space provides Space Safety and Security data & services of unprecedented quality, with a dedicated, sovereign and secure sensor network and state-of-the-art data processing capabilities. | $27.6M / Series A / Jun 11, 2025 | |
CoreMedic GmbH
|
CoreMedic develops and manufactures devices and therapies to address the treatment of heart valve diseases. It offers ChordArt, a mitral valve repair system which focuses on the minimally invasive, trans-femoral repair at the beating heart. CoreMedic is developing two systems which facilitate delivery and deployment of the implant. Additionally,it provides ChordArt S, which reduces invasiveness of the surgical procedure by repairing the valve in a way which allows the surgeon to focus on the procedure and timing rather than manually placing the sutures to repair the valve; and ChordArt C which allows for the valve repair to be carried out via the vascular route through a tiny incision in the groin. CoreMedic began operation in June 2012. It has its headquarters in Biel/Bienne in Switzerland. | Series B / Feb 11, 2025 | |
Liva Healthcare
|
Liva Healthcare is an innovative digital health coaching platform for scalable lifestyle and disease management.Winner of 'Health IT Firm of the Year' at the HealthInvestor Awards 2018 and 'Healthtech Innovators of the Year - Europe' at the Global Health & Pharma Awards 2018, Liva Healthcare is used by public healthcare,private insurance and pharma companies including NHS England and AXA PPP Healthcare.Liva Healthcare’s platform facilitates ongoing personalized health coaching through an intuitive app, building a strong bond between coach, GP, and patient. Its focus lies on tackling chronic illnesses, such as Type 2 diabetes, obesity, and heart disease by driving behavior change.The app is multilingual across several languages, proven to work efficiently across all socio-economic backgrounds, and is capable of engaging groups normally hard to reach. It is based upon nine to 18 months of continuous patient engagement to make new habits and behaviors stick. One coach can manage 500 patients per year simultaneously without the loss of patient outcomes.Implementation time from the get-go is normally within weeks and the platform is available as a white-label SaaS platform or as a turn-key solution, dependent on client specifications.Liva Healthcare has offices in Copenhagen, Denmark, and London, UK. | Venture - Series Unknown / Feb 05, 2025 | |
Inbolt
|
InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters. | $16.7M / Series A / Sep 19, 2024 | |
SciRhom
|
SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development. | $68.1M / Series A / Jul 09, 2024 | |
| See all 97 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does MIG Capital invest in?
MIG Capital invests primarily in Biotechnology, Health Care and Software startups, most often at Series A and Series B stage. Most of the 97 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is MIG Capital's check size?
MIG Capital typically joins rounds of $2.2M–$40M at Series A and $1.6M–$60M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds MIG Capital participates in.
How do I contact MIG Capital?
Public channels for MIG Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at MIG Capital?
The team at MIG Capital includes Axel Thierauf (Venture Partner), Boris Bernstein (Venture Partner) and Dr. Klaus Feix (Venture Partner), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
